Impact of host IL28B rs12979860, rs8099917 in interferon responsiveness and advanced liver disease in chronic genotype 3 hepatitis C patients

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Firdaus, Rushna ^a   Biswas, Aritra ^a   Saha, Kallol ^a   Mukherjee, Anirban ^a   Chaudhuri, Sujit ^b   Chandra, Alok ^c   Konar, Asokananda ^d   Sadhukhan, Provash Chandra ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b AMRI HOSPITALS   (India)

^c Department of Medicine and Gastroenterology Command Hospital ^*  (India)

^d PEERLESS HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 28B; PEGINTERFERON; RIBAVIRIN; VIRUS RNA; ALPHA INTERFERON; IL28B PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; ADVANCED LIVER DISEASE; ALLELE; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 3; HUMAN; INDIA; INTERLEUKIN 28B GENE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; VIROLOGY; VIRUS LOAD; DEMOGRAPHY; GENE FREQUENCY; GENETICS; GENOTYPING TECHNIQUE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HOST PATHOGEN INTERACTION; LIVER; PATHOLOGY; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENOTYPE; GENOTYPING TECHNIQUES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-ALPHA; INTERLEUKINS; LIVER; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84902602812     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099126     Document Type: Article

References (25)

1. WHO (1999) Global surveillance and control of hepatitis C. Report of a WHO Consultation organised with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hep 6: 35-47.
2. WHO, World health organization. Hepatitis C surveillance and control. Available: http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/index4. html#incidence. Accessed November 19, 2013.
3. Centers for Disease Control and Prevention (1998) Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 47(RR-19): 1-39.
4. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, et al. (2014) Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource. Hepatol 59(1): 318-27.
5. Chakravarti A, Dogra G, Verma V and Srivastava AP (2011) Distribution pattern of HCV genotypes & its association with viral load. Ind J Med Res 133 (3): 326-31.
6. Das BR, Kundu B, Khandapkar R, and Sahni S (2002) Geographical distribution of hepatitis C virus genotypes in India. Ind J Path Microbiol 45(3): 323-28.
7. Bruno S, Silini E, Crosignani A, Borzio F, Leandro G, et al. (1997) Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. J Hepatol 25: 754-758. (Pubitemid 27106466)
8. Castéra L, Hézode C, Roudot-Thoraval F, Lonjon I, Zafrani ES, et al. (2004) Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis. Gut 53: 420-424. (Pubitemid 38241341)
9. Asselah T (2012) Genetic polymorphism and response to treatment in chronic hepatitis C: the future of personalized medicine. J Hepatol 52: 452-4.
10. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, et al. (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347(13): 975-82.
11. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401.
12. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, et al. (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41: 1105-1109.
13. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, et al. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41: 1100-1104.
14. Kiser JJ, Flexner C (2013) Direct-acting antiviral agents for hepatitis C virus infection. Annu Rev Pharmacol Toxicol 53: 427-49.
15. Omata M, Kanda T, Yu M, Yokosuka O, Lim S, et al. (2012) APASL consensus statements and management algorithms for hepatitis C virus infection. Hepatol Int 6: 409-435.
16. Ezzikouri S, Alaoui R, Rebbani K, Brahim I, Fakhir FZ, et al. (2013) Genetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in Moroccan patients. PLoS One 8(1): e54793.
17. Saha K, Firdaus R, Santra P, Pal J, Roy A, et al.(2011) Recent Pattern of Co-infection amongst HIV Seropositive individuals in Tertiary Care Hospital, Kolkata. Virol J 8: 116.
18. Rozanov M, Plikat U, Chappey C, Kochergin A, Tatusova T (2004) A web-based genotyping resource for viral sequences. Nucleic Acids Res 32 (Web Server issue): W654-9. Availiable: http://www.ncbi.nlm.nih.gov/projects/ genotyping/formpage.cgi. Accessed 2014 May 15.
19. Horner SM, Gale M Jr (2009) Intracellular innate immune cascades and interferon defenses that control hepatitis C virus. J Interferon Cytokine Res 29(9): 489-98.
20. McHutchison JG, Poynard T, Pianko S, Gordon SC, Reid AE, et al. (2000) The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. Gastroenterol 119: 1317-1323.
21. Gonzalez SA, Keeffe EB (2011) IL-28B as a Predictor of Sustained Virologic Response in Patients with Chronic Hepatitis C Virus Infection. Gastroenterol Hepatol (NY) 7(6): 366-73.
22. Hoofnagle JH (2002) Course and outcome of hepatitis C. Hepatol 36(Suppl) 1: S21-9.
23. Sivaprasad S, Rao PN, Gupta R, Ashwini K, Reddy DN (2012) The Distribution of Genotype and Allelic Frequency of IL28B Gene Polymorphism in Andhra Pradesh, India. J Clin Exp Hepatol 2(1): 112-115.
24. Lutz P, Wasmuth JC, Nischalke HD, Vidovic N, Grünhagei F, et al. (2011) Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rs12979860 polymorphism of the IL28B gene. Eur J Med Res16 (8): 335-41.
25. Rembeck K, Alsio A, Christensen PB, Farkkila M, Langeland N, et al. (2012) Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3. PLoS One 7: e29370 (doi:10.1371/journal.pone.0029370).